These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 31528095)

  • 21. Effect of moxibustion on the expression of GDNF and its receptor GFRα3 in the colon and spinal cord of rats with irritable bowel syndrome.
    Qi Q; Wu H; Jin X; Jin D; Wang Y; Wang C; Liu Y; Wang X
    Acupunct Med; 2019 Aug; 37(4):244-251. PubMed ID: 31188015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effects of Rifaximin in post-infectious irritable bowel syndrome mouse model beyond gut microbiota.
    Jin Y; Ren X; Li G; Li Y; Zhang L; Wang H; Qian W; Hou X
    J Gastroenterol Hepatol; 2018 Feb; 33(2):443-452. PubMed ID: 28573746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of mild moxibustion on intestinal microbiome and NLRP3 inflammasome in rats with 5-fluorouracil-induced intestinal mucositis.
    Li BR; Shao SY; Yuan L; Jia R; Sun J; Ji Q; Sui H; Zhou LH; Zhang Y; Liu H; Li Q; Wang Y; Zhang BM
    J Integr Med; 2021 Mar; 19(2):144-157. PubMed ID: 33353843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota was modulated by moxibustion stimulation in rats with irritable bowel syndrome.
    Wang X; Qi Q; Wang Y; Wu H; Jin X; Yao H; Jin D; Liu Y; Wang C
    Chin Med; 2018; 13():63. PubMed ID: 30574173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of heat-sensitive moxibustion on HPA axis in rats with irritable bowel syndrome].
    Zhang H; Xie F; Gong H; Huang H; Chen S; Kang M; Fu Y
    Zhongguo Zhen Jiu; 2017 Dec; 37(12):1315-21. PubMed ID: 29354998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of
    Cao YN; Feng LJ; Liu YY; Jiang K; Zhang MJ; Gu YX; Wang BM; Gao J; Wang ZL; Wang YM
    World J Gastroenterol; 2018 Jan; 24(3):338-350. PubMed ID: 29391756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome.
    Compare D; Rocco A; Coccoli P; Angrisani D; Sgamato C; Iovine B; Salvatore U; Nardone G
    BMC Gastroenterol; 2017 Apr; 17(1):53. PubMed ID: 28410580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats.
    Yu ZC; Cen YX; Wu BH; Wei C; Xiong F; Li DF; Liu TT; Luo MH; Guo LL; Li YX; Wang LS; Wang JY; Yao J
    World J Gastroenterol; 2019 Aug; 25(29):3956-3971. PubMed ID: 31413530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Influence of moxibustion with different duration on colonic epithelial structure, serum inflammatory cytokines, and intestinal mucosa inflammatory cell signal transduction pathways].
    Ma TM; Han Y; Ma XD; Zeng XX; Ge W
    Zhen Ci Yan Jiu; 2014 Feb; 39(1):20-6. PubMed ID: 24684107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colonic mucosal N-methyl-D-aspartate receptor mediated visceral hypersensitivity in a mouse model of irritable bowel syndrome.
    Qi QQ; Chen FX; Zhao DY; Li LX; Wang P; Li YQ; Zuo XL
    J Dig Dis; 2016 Jul; 17(7):448-57. PubMed ID: 27356126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanism of acupuncture-moxibustion with "Biao-Ben" acupoint combination in treating irritable bowel syndrome rats by regulating serum metabolites and metabolic pathway based on TM widely targeted metabolomics method].
    Fu YM; Liang FX; Li J; Wu S; Wang H
    Zhen Ci Yan Jiu; 2023 Apr; 48(4):339-46. PubMed ID: 37186197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tranilast alleviates visceral hypersensitivity and colonic hyperpermeability by suppressing NLRP3 inflammasome activation in irritable bowel syndrome rat models.
    Nozu T; Arie H; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Int Immunopharmacol; 2024 May; 133():112099. PubMed ID: 38643709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Electroacupuncture Relieves Visceral Hypersensitivity by Down-regulating Mast Cell Number，PAR-2/TRPV 1 Signaling, etc. in Colonic Tissue of Rats with Irritable Bowel Syndrome].
    Deng DX; Tan J; Zhang H; Huang GL; Li S; Guo KK; Wu YY; Yang BY; Xiao Y; Peng L; Xie H
    Zhen Ci Yan Jiu; 2018 Aug; 43(8):485-91. PubMed ID: 30232850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effects of moxibustion and acupuncture of combined "Biao-Ben" acupoints on intestinal sensitivity and autonomic nervous system function in rats with diarrhea-predominant irritable bowel syndrome.
    Zhou XL; Wang H; Wu S; Li J; Wu F; Lu W; Zhao JW; Li YH
    Zhen Ci Yan Jiu; 2023 Nov; 48(11):1134-1141. PubMed ID: 37984911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The NLRP6 inflammasome.
    Zheng D; Kern L; Elinav E
    Immunology; 2021 Mar; 162(3):281-289. PubMed ID: 33314083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moxibustion eases chronic inflammatory visceral pain through regulating MEK, ERK and CREB in rats.
    Li ZY; Huang Y; Yang YT; Zhang D; Zhao Y; Hong J; Liu J; Wu LJ; Zhang CH; Wu HG; Zhang J; Ma XP
    World J Gastroenterol; 2017 Sep; 23(34):6220-6230. PubMed ID: 28974888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of altered gut microbiota on visceral hypersensitivity of postinfectious irritable bowel syndrome mice.
    Cheng F; Fan Z; Lin C; Zhu Y; He H; Dai N; Du L
    Eur J Gastroenterol Hepatol; 2022 Dec; 34(12):1220-1230. PubMed ID: 36165068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BRCC3 promotes activation of the NLRP6 inflammasome following cerebral ischemia/reperfusion (I/R) injury in rats.
    Huang X; Gan H; Tan J; Wang T; Zhao J; Zhao Y
    Neurosci Lett; 2021 Jun; 756():135954. PubMed ID: 33979701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chitin-glucan improves important pathophysiological features of irritable bowel syndrome.
    Valibouze C; Dubuquoy C; Chavatte P; Genin M; Maquet V; Modica S; Desreumaux P; Rousseaux C
    World J Gastroenterol; 2024 Apr; 30(16):2258-2271. PubMed ID: 38690023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Key factors in developing the trinitrobenzene sulfonic acid-induced post-inflammatory irritable bowel syndrome model in rats.
    Qin HY; Xiao HT; Wu JC; Berman BM; Sung JJ; Bian ZX
    World J Gastroenterol; 2012 May; 18(20):2481-92. PubMed ID: 22654445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.